Table 2 Bowel preparations and time to colonoscopy.
From: A colonoscopy quality improvement intervention in an endoscopy unit
Phase 1 | Phase 2 | p | |||
|---|---|---|---|---|---|
N = 134 | (%) | N = 133 | (%) | ||
Preparation | |||||
PEG 4 L | 36 | 26.9 | 2 | 1.5 | 0.0001 |
PEG 2 L + ascorbic acid | 68 | 50.7 | 115 | 86.5 | |
Sodium phosphate drinkable | 3 | 2.2 | 0 | 0.0 | |
Sodium phosphate tablets | 1 | 0.8 | 3 | 2.2 | |
Sodium Picosulfate | 25 | 18.6 | 11 | 8.3 | |
Enemas | 1 | 0.8 | 2 | 1.5 | |
Splitting | |||||
None | 24 | 17.9 | 4 | 3 | 0.0001 |
2 takes one day before | 74 | 55.2 | 0 | 0 | |
Split dosing | 36 | 26.9 | 128 | 97 | |
Schedule | |||||
Morning | 122 | 91 | 113 | 85 | 0.13 |
Afternoon | 12 | 9 | 20 | 15 | |
End of take | n = 105 | N = 131 | |||
3–5 h | 26 | 24.8 | 125 | 95.4 | 0.0001 |
5–8 h | 3 | 2.8 | 3 | 2.3 | |
> 8 h | 76 | 72.4 | 3 | 2.3 | |
Acceptability | n = 70 | 69 | |||
Excellent | 3 | 4.3 | 8 | 11.6 | 0.9 |
Good | 59 | 85.3 | 56 | 81.2 | |
Middle | 5 | 7.1 | 3 | 4.3 | |
Bad | 3 | 4.3 | 2 | 2.9 | |
Very bad | 0 | 0.0 | 0 | 0.0 | |
Times (days) | N = 132 | N = 133 | p | ||
|---|---|---|---|---|---|
Median | (IQR) | Median | (IQR) | ||
Addressing practitioner—GE | 18 | [7–31] | 36.5 | [13–63] | 0.0001 |
GE—anesthesiologist | 22 | [9–36] | 37 | [21–49] | 0.0003 |
GE—colonoscopy | 38 | [2–52] | 53 | [35–64] | 0.0001 |
For FIT | N = 30 | N = 6 | |||
FIT—GE | 33.5 | [27–42] | 52.5 | [40–81] | 0.1 |
Addressing practitioner—GE | 20 | [15–28] | 35 | [28–60] | 0.07 |
GE—Colonoscopy | 36.5 | [26–39] | 52 | [32–63] | 0.1 |
FIT—Colonoscopy | 69 | [58–97] | 108 | [103–136] | 0.02 |
